Chronic renal failure
Conditions
Interventions
control group:Basic treatment
Sponsors
Shuguang Hospital, affiliated to Shanghai University of Traditional Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: (1)The signing of the informed consent. (2)Aged 18-80 years. (3)The patients with ckd5 of chronic renal failure were blood stasis syndrome. (4)There were early abnormal bone metabolism or calcium and phosphorus metabolism.
Exclusion criteria
Exclusion criteria: (1)People with serious primary diseases such as heart, brain, liver and hematopoiesis. (2)After kidney transplantation, patients with psychosis or diabetic. (3)Patients with acute renal failure. (4)Pregnant or lactating women. (5)Patients who are known to be allergic to the drugs used. (6)People who are participating in other drug clinical trials or in other clinical trials within 3 months or other drugs that have been used to control thrombus. (7)Other circumstances in which the researcher considers it inappropriate to participate in this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Blood phosphorus;blood calcium;alkaline phosphatase;Asymmetric-dimethylation arginine;Vitamin D3;parathyroid hormone;Fibroblast Growth Factor23;Klotho;Matrix Gla protein;Fetuin A;bone morphogenetic protein-2;Calcitonin;Bone density;Pulse wave velocity;Arterial enhancement index;Brachial ankle index; | — |
Secondary
| Measure | Time frame |
|---|---|
| Malondialdehyde;Superoxide dismutase;C-reactive protein;Interleukin-; | — |
Countries
China
Contacts
Public ContactYe Chaoyang
Shuguang Hospital, affiliated to Shanghai University of Traditional Chinese Medicine
Outcome results
None listed